1. Home
  2. ATYR vs CMCM Comparison

ATYR vs CMCM Comparison

Compare ATYR & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.71

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo Cheetah Mobile Inc. each representing fifty (50)

CMCM

Cheetah Mobile Inc. each representing fifty (50)

HOLD

Current Price

$6.59

Market Cap

195.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
CMCM
Founded
2005
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
195.2M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
ATYR
CMCM
Price
$0.71
$6.59
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
2.3M
51.1K
Earning Date
11-06-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$190,000.00
$151,517,306.00
Revenue This Year
N/A
$14.27
Revenue Next Year
$18,728.88
$39.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
46.34
52 Week Low
$0.64
$3.28
52 Week High
$7.29
$9.44

Technical Indicators

Market Signals
Indicator
ATYR
CMCM
Relative Strength Index (RSI) 36.93 43.30
Support Level $0.70 $6.55
Resistance Level $0.83 $6.90
Average True Range (ATR) 0.05 0.35
MACD 0.01 -0.03
Stochastic Oscillator 4.95 11.68

Price Performance

Historical Comparison
ATYR
CMCM

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

Share on Social Networks: